nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—DRD1—obesity	0.165	0.383	CbGaD
Triflupromazine—BCHE—obesity	0.15	0.348	CbGaD
Triflupromazine—DRD1—Phenylpropanolamine—obesity	0.141	0.868	CbGbCtD
Triflupromazine—DRD2—obesity	0.116	0.27	CbGaD
Triflupromazine—Ethopropazine—Diethylpropion—obesity	0.1	0.339	CrCrCtD
Triflupromazine—Ethopropazine—Benzphetamine—obesity	0.0585	0.198	CrCrCtD
Triflupromazine—Promethazine—Benzphetamine—obesity	0.0484	0.164	CrCrCtD
Triflupromazine—Alimemazine—Benzphetamine—obesity	0.0476	0.161	CrCrCtD
Triflupromazine—Promazine—Benzphetamine—obesity	0.041	0.139	CrCrCtD
Triflupromazine—ABCB1—Cimetidine—obesity	0.0214	0.132	CbGbCtD
Triflupromazine—BCHE—diaphragm—obesity	0.00357	0.289	CbGeAlD
Triflupromazine—DRD2—hindbrain—obesity	0.000737	0.0595	CbGeAlD
Triflupromazine—CHRM2—cardiovascular system—obesity	0.00047	0.038	CbGeAlD
Triflupromazine—HTR2B—adrenal cortex—obesity	0.000466	0.0377	CbGeAlD
Triflupromazine—DRD2—respiratory system—obesity	0.00045	0.0364	CbGeAlD
Triflupromazine—CHRM1—cardiovascular system—obesity	0.000428	0.0346	CbGeAlD
Triflupromazine—HTR2B—cardiovascular system—obesity	0.000426	0.0344	CbGeAlD
Triflupromazine—BCHE—respiratory system—obesity	0.000408	0.033	CbGeAlD
Triflupromazine—HTR2B—adipose tissue—obesity	0.000375	0.0303	CbGeAlD
Triflupromazine—HTR2B—digestive system—obesity	0.000353	0.0286	CbGeAlD
Triflupromazine—HTR2B—adrenal gland—obesity	0.000337	0.0272	CbGeAlD
Triflupromazine—CHRM2—endocrine gland—obesity	0.000322	0.0261	CbGeAlD
Triflupromazine—BCHE—cardiovascular system—obesity	0.000312	0.0253	CbGeAlD
Triflupromazine—DRD2—pituitary gland—obesity	0.000305	0.0247	CbGeAlD
Triflupromazine—CHRM1—endocrine gland—obesity	0.000293	0.0237	CbGeAlD
Triflupromazine—BCHE—pituitary gland—obesity	0.000277	0.0224	CbGeAlD
Triflupromazine—BCHE—adipose tissue—obesity	0.000276	0.0223	CbGeAlD
Triflupromazine—BCHE—digestive system—obesity	0.000259	0.021	CbGeAlD
Triflupromazine—BCHE—adrenal gland—obesity	0.000247	0.02	CbGeAlD
Triflupromazine—DRD2—endocrine gland—obesity	0.000236	0.0191	CbGeAlD
Triflupromazine—BCHE—endocrine gland—obesity	0.000214	0.0173	CbGeAlD
Triflupromazine—ABCB1—islet of Langerhans—obesity	0.000206	0.0166	CbGeAlD
Triflupromazine—ABCB1—respiratory system—obesity	0.000194	0.0157	CbGeAlD
Triflupromazine—BCHE—liver—obesity	0.000193	0.0156	CbGeAlD
Triflupromazine—ABCB1—adrenal cortex—obesity	0.000163	0.0132	CbGeAlD
Triflupromazine—ABCB1—cardiovascular system—obesity	0.000149	0.012	CbGeAlD
Triflupromazine—Acetophenazine—DRD1—obesity	0.000133	0.0311	CrCbGaD
Triflupromazine—ABCB1—pituitary gland—obesity	0.000132	0.0107	CbGeAlD
Triflupromazine—ABCB1—adipose tissue—obesity	0.000131	0.0106	CbGeAlD
Triflupromazine—ABCB1—digestive system—obesity	0.000124	0.00999	CbGeAlD
Triflupromazine—ABCB1—adrenal gland—obesity	0.000118	0.00952	CbGeAlD
Triflupromazine—Propericiazine—DRD1—obesity	0.000117	0.0275	CrCbGaD
Triflupromazine—ABCB1—endocrine gland—obesity	0.000102	0.00826	CbGeAlD
Triflupromazine—Cyamemazine—HTR2C—obesity	0.0001	0.0235	CrCbGaD
Triflupromazine—Acetophenazine—DRD2—obesity	9.37e-05	0.0219	CrCbGaD
Triflupromazine—Acepromazine—SLC22A1—obesity	9.23e-05	0.0216	CrCbGaD
Triflupromazine—ABCB1—liver—obesity	9.21e-05	0.00744	CbGeAlD
Triflupromazine—Ethopropazine—BCHE—obesity	9.04e-05	0.0211	CrCbGaD
Triflupromazine—Thioproperazine—SLC22A1—obesity	9.02e-05	0.0211	CrCbGaD
Triflupromazine—Pipotiazine—SLC22A1—obesity	8.88e-05	0.0208	CrCbGaD
Triflupromazine—Acepromazine—DRD1—obesity	7.55e-05	0.0176	CrCbGaD
Triflupromazine—Thioproperazine—DRD1—obesity	7.38e-05	0.0172	CrCbGaD
Triflupromazine—Pipotiazine—DRD1—obesity	7.26e-05	0.017	CrCbGaD
Triflupromazine—Propiomazine—DRD4—obesity	7.13e-05	0.0167	CrCbGaD
Triflupromazine—Cyamemazine—HTR2A—obesity	6.4e-05	0.015	CrCbGaD
Triflupromazine—Fluphenazine—DRD1—obesity	6.27e-05	0.0147	CrCbGaD
Triflupromazine—Mesoridazine—HTR2C—obesity	6.13e-05	0.0143	CrCbGaD
Triflupromazine—Methotrimeprazine—DRD4—obesity	6.09e-05	0.0142	CrCbGaD
Triflupromazine—Propiomazine—DRD1—obesity	6.03e-05	0.0141	CrCbGaD
Triflupromazine—Prochlorperazine—HTR2C—obesity	5.93e-05	0.0139	CrCbGaD
Triflupromazine—Chlorprothixene—DRD1—obesity	5.71e-05	0.0133	CrCbGaD
Triflupromazine—Desipramine—SLC22A1—obesity	5.65e-05	0.0132	CrCbGaD
Triflupromazine—Thioridazine—DRD1—obesity	5.4e-05	0.0126	CrCbGaD
Triflupromazine—Fluphenazine—HTR2C—obesity	5.36e-05	0.0125	CrCbGaD
Triflupromazine—Acepromazine—DRD2—obesity	5.32e-05	0.0124	CrCbGaD
Triflupromazine—Promazine—DRD4—obesity	5.28e-05	0.0123	CrCbGaD
Triflupromazine—Thioproperazine—DRD2—obesity	5.2e-05	0.0122	CrCbGaD
Triflupromazine—Propiomazine—HTR2C—obesity	5.16e-05	0.0121	CrCbGaD
Triflupromazine—Methotrimeprazine—DRD1—obesity	5.16e-05	0.0121	CrCbGaD
Triflupromazine—Pipotiazine—DRD2—obesity	5.12e-05	0.012	CrCbGaD
Triflupromazine—Mesoridazine—DRD2—obesity	5.05e-05	0.0118	CrCbGaD
Triflupromazine—Perphenazine—DRD1—obesity	4.96e-05	0.0116	CrCbGaD
Triflupromazine—Clomipramine—HTR2C—obesity	4.91e-05	0.0115	CrCbGaD
Triflupromazine—Prochlorperazine—DRD2—obesity	4.89e-05	0.0114	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2C—obesity	4.89e-05	0.0114	CrCbGaD
Triflupromazine—Chlorpromazine—SLC22A1—obesity	4.81e-05	0.0113	CrCbGaD
Triflupromazine—Imipramine—SLC22A1—obesity	4.79e-05	0.0112	CrCbGaD
Triflupromazine—Chlorpromazine—DRD4—obesity	4.65e-05	0.0109	CrCbGaD
Triflupromazine—Thioridazine—HTR2C—obesity	4.62e-05	0.0108	CrCbGaD
Triflupromazine—Promazine—DRD1—obesity	4.47e-05	0.0104	CrCbGaD
Triflupromazine—Fluphenazine—DRD2—obesity	4.42e-05	0.0103	CrCbGaD
Triflupromazine—Methotrimeprazine—HTR2C—obesity	4.41e-05	0.0103	CrCbGaD
Triflupromazine—Trifluoperazine—HTR2C—obesity	4.29e-05	0.01	CrCbGaD
Triflupromazine—Desipramine—ADRB1—obesity	4.28e-05	0.01	CrCbGaD
Triflupromazine—Fluphenazine—CYP2E1—obesity	4.26e-05	0.00995	CrCbGaD
Triflupromazine—Propiomazine—DRD2—obesity	4.25e-05	0.00994	CrCbGaD
Triflupromazine—Perphenazine—HTR2C—obesity	4.24e-05	0.00992	CrCbGaD
Triflupromazine—Acepromazine—HTR2A—obesity	4.11e-05	0.00961	CrCbGaD
Triflupromazine—Clomipramine—SLC6A4—obesity	4.07e-05	0.0095	CrCbGaD
Triflupromazine—Chlorprothixene—DRD2—obesity	4.03e-05	0.00941	CrCbGaD
Triflupromazine—Thioproperazine—HTR2A—obesity	4.02e-05	0.00939	CrCbGaD
Triflupromazine—Pipotiazine—HTR2A—obesity	3.95e-05	0.00924	CrCbGaD
Triflupromazine—Desipramine—HTR2C—obesity	3.95e-05	0.00923	CrCbGaD
Triflupromazine—Chlorpromazine—DRD1—obesity	3.93e-05	0.0092	CrCbGaD
Triflupromazine—Mesoridazine—HTR2A—obesity	3.9e-05	0.00912	CrCbGaD
Triflupromazine—Promazine—HTR2C—obesity	3.82e-05	0.00894	CrCbGaD
Triflupromazine—Thioridazine—DRD2—obesity	3.81e-05	0.0089	CrCbGaD
Triflupromazine—Thioridazine—CYP2E1—obesity	3.67e-05	0.00857	CrCbGaD
Triflupromazine—Methotrimeprazine—DRD2—obesity	3.64e-05	0.0085	CrCbGaD
Triflupromazine—Desipramine—ADRB2—obesity	3.6e-05	0.00842	CrCbGaD
Triflupromazine—Promethazine—DRD2—obesity	3.58e-05	0.00837	CrCbGaD
Triflupromazine—Chlorpromazine—BCHE—obesity	3.57e-05	0.00835	CrCbGaD
Triflupromazine—Trifluoperazine—DRD2—obesity	3.53e-05	0.00826	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP2E1—obesity	3.5e-05	0.00818	CrCbGaD
Triflupromazine—Perphenazine—DRD2—obesity	3.5e-05	0.00817	CrCbGaD
Triflupromazine—Fluphenazine—HTR2A—obesity	3.42e-05	0.00799	CrCbGaD
Triflupromazine—Chlorpromazine—HTR2C—obesity	3.37e-05	0.00787	CrCbGaD
Triflupromazine—Imipramine—HTR2C—obesity	3.35e-05	0.00783	CrCbGaD
Triflupromazine—Propiomazine—HTR2A—obesity	3.29e-05	0.00768	CrCbGaD
Triflupromazine—Desipramine—SLC6A4—obesity	3.27e-05	0.00765	CrCbGaD
Triflupromazine—Desipramine—DRD2—obesity	3.25e-05	0.00761	CrCbGaD
Triflupromazine—Promazine—DRD2—obesity	3.15e-05	0.00737	CrCbGaD
Triflupromazine—Desipramine—CYP2E1—obesity	3.13e-05	0.00732	CrCbGaD
Triflupromazine—Clomipramine—HTR2A—obesity	3.12e-05	0.0073	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2A—obesity	3.11e-05	0.00727	CrCbGaD
Triflupromazine—Thioridazine—HTR2A—obesity	2.94e-05	0.00688	CrCbGaD
Triflupromazine—Acepromazine—ALB—obesity	2.81e-05	0.00658	CrCbGaD
Triflupromazine—Methotrimeprazine—HTR2A—obesity	2.81e-05	0.00657	CrCbGaD
Triflupromazine—Imipramine—SLC6A4—obesity	2.77e-05	0.00649	CrCbGaD
Triflupromazine—Chlorpromazine—DRD2—obesity	2.77e-05	0.00648	CrCbGaD
Triflupromazine—Promethazine—HTR2A—obesity	2.77e-05	0.00647	CrCbGaD
Triflupromazine—Imipramine—DRD2—obesity	2.76e-05	0.00645	CrCbGaD
Triflupromazine—Thioproperazine—ALB—obesity	2.75e-05	0.00643	CrCbGaD
Triflupromazine—Trifluoperazine—HTR2A—obesity	2.73e-05	0.00638	CrCbGaD
Triflupromazine—Pipotiazine—ALB—obesity	2.7e-05	0.00632	CrCbGaD
Triflupromazine—Perphenazine—HTR2A—obesity	2.7e-05	0.00632	CrCbGaD
Triflupromazine—Chlorpromazine—CYP2E1—obesity	2.67e-05	0.00624	CrCbGaD
Triflupromazine—Imipramine—CYP2E1—obesity	2.66e-05	0.00621	CrCbGaD
Triflupromazine—Desipramine—HTR2A—obesity	2.51e-05	0.00588	CrCbGaD
Triflupromazine—Promazine—HTR2A—obesity	2.44e-05	0.00569	CrCbGaD
Triflupromazine—Chlorpromazine—HTR2A—obesity	2.14e-05	0.00501	CrCbGaD
Triflupromazine—Clomipramine—ALB—obesity	2.14e-05	0.005	CrCbGaD
Triflupromazine—Imipramine—HTR2A—obesity	2.13e-05	0.00498	CrCbGaD
Triflupromazine—Chlorpromazine—ALB—obesity	1.47e-05	0.00343	CrCbGaD
Triflupromazine—CHRM2—Signaling by GPCR—TYK2—obesity	4.17e-06	4.38e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CB—obesity	4.16e-06	4.37e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF2—obesity	4.15e-06	4.36e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3R1—obesity	4.14e-06	4.35e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—RHOA—obesity	4.13e-06	4.34e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ALB—obesity	4.13e-06	4.34e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—FASN—obesity	4.13e-06	4.33e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—BAD—obesity	4.12e-06	4.33e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GNAS—obesity	4.12e-06	4.32e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—BCHE—obesity	4.11e-06	4.31e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3R1—obesity	4.09e-06	4.3e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOB—obesity	4.08e-06	4.29e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL5—obesity	4.07e-06	4.28e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOB—obesity	4.03e-06	4.23e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—POMC—obesity	4.03e-06	4.23e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CD—obesity	4.02e-06	4.22e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—INS—obesity	4.01e-06	4.21e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CG—obesity	3.99e-06	4.19e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL5—obesity	3.99e-06	4.19e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LPL—obesity	3.98e-06	4.18e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALB—obesity	3.97e-06	4.17e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP2E1—obesity	3.96e-06	4.16e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FOXO1—obesity	3.96e-06	4.15e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RPS6KB1—obesity	3.95e-06	4.14e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IRS1—obesity	3.95e-06	4.14e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL2—obesity	3.94e-06	4.14e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL5—obesity	3.94e-06	4.13e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NQO1—obesity	3.92e-06	4.12e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CB—obesity	3.91e-06	4.1e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LPL—obesity	3.9e-06	4.09e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF1—obesity	3.88e-06	4.07e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT2—obesity	3.87e-06	4.07e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FOXO1—obesity	3.87e-06	4.06e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RPS6KB1—obesity	3.86e-06	4.06e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LPL—obesity	3.85e-06	4.04e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CB—obesity	3.83e-06	4.02e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FOXO1—obesity	3.82e-06	4.01e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RPS6KB1—obesity	3.81e-06	4e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—POMC—obesity	3.8e-06	3.99e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—NOS3—obesity	3.8e-06	3.98e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3R1—obesity	3.8e-06	3.98e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—INS—obesity	3.78e-06	3.97e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CB—obesity	3.78e-06	3.96e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC2A4—obesity	3.76e-06	3.95e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GCG—obesity	3.76e-06	3.95e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CD—obesity	3.72e-06	3.91e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL2—obesity	3.72e-06	3.9e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYCS—obesity	3.71e-06	3.89e-05	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—PIK3CA—obesity	3.69e-06	3.87e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SERPINE1—obesity	3.68e-06	3.86e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PRKCD—obesity	3.67e-06	3.85e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF1—obesity	3.65e-06	3.84e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT2—obesity	3.65e-06	3.83e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GOT1—obesity	3.64e-06	3.82e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GGT1—obesity	3.64e-06	3.82e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PRKCD—obesity	3.59e-06	3.77e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR2A—obesity	3.59e-06	3.77e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—C3—obesity	3.59e-06	3.77e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NCOA1—obesity	3.59e-06	3.76e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TYK2—obesity	3.58e-06	3.76e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RHOA—obesity	3.55e-06	3.73e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PRKCD—obesity	3.55e-06	3.72e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—STK11—obesity	3.53e-06	3.71e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP19A1—obesity	3.53e-06	3.71e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR2A—obesity	3.52e-06	3.69e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3R1—obesity	3.51e-06	3.69e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOS3—obesity	3.51e-06	3.69e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—C3—obesity	3.51e-06	3.69e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CD—obesity	3.51e-06	3.68e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CB—obesity	3.5e-06	3.68e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—PIK3CA—obesity	3.48e-06	3.65e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—obesity	3.47e-06	3.64e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SERPINE1—obesity	3.47e-06	3.64e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR2A—obesity	3.47e-06	3.64e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—C3—obesity	3.47e-06	3.64e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS2—obesity	3.41e-06	3.58e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGT—obesity	3.41e-06	3.58e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TYK2—obesity	3.38e-06	3.54e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RHOA—obesity	3.35e-06	3.51e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PIK3CA—obesity	3.35e-06	3.51e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS2—obesity	3.34e-06	3.51e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOE—obesity	3.34e-06	3.51e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LEP—obesity	3.34e-06	3.51e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGT—obesity	3.34e-06	3.5e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3R1—obesity	3.31e-06	3.48e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOS3—obesity	3.31e-06	3.48e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CAV1—obesity	3.31e-06	3.47e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOA1—obesity	3.3e-06	3.47e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS2—obesity	3.3e-06	3.46e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGT—obesity	3.29e-06	3.46e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—COMT—obesity	3.29e-06	3.45e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LEP—obesity	3.27e-06	3.43e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOE—obesity	3.27e-06	3.43e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MTOR—obesity	3.24e-06	3.4e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CB—obesity	3.24e-06	3.4e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARGC1A—obesity	3.24e-06	3.4e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GNB3—obesity	3.24e-06	3.4e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CAV1—obesity	3.24e-06	3.4e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOA1—obesity	3.23e-06	3.39e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOE—obesity	3.23e-06	3.39e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—obesity	3.23e-06	3.39e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—obesity	3.22e-06	3.39e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CAV1—obesity	3.2e-06	3.36e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOA1—obesity	3.19e-06	3.35e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ESR1—obesity	3.19e-06	3.35e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PIK3CA—obesity	3.16e-06	3.31e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GNAS—obesity	3.15e-06	3.31e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—F2—obesity	3.15e-06	3.31e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PRKCB—obesity	3.15e-06	3.31e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ESR1—obesity	3.12e-06	3.28e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BAD—obesity	3.11e-06	3.27e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOB—obesity	3.09e-06	3.24e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PRKCB—obesity	3.08e-06	3.24e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—F2—obesity	3.08e-06	3.24e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ESR1—obesity	3.08e-06	3.23e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MTOR—obesity	3.06e-06	3.21e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CB—obesity	3.06e-06	3.21e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BAD—obesity	3.05e-06	3.2e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PRKCB—obesity	3.04e-06	3.19e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—F2—obesity	3.04e-06	3.19e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CG—obesity	3.01e-06	3.16e-05	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—obesity	3.01e-06	3.16e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BAD—obesity	3.01e-06	3.16e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS1—obesity	2.98e-06	3.13e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—obesity	2.96e-06	3.11e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CG—obesity	2.95e-06	3.1e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—LPL—obesity	2.95e-06	3.1e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS1—obesity	2.92e-06	3.06e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CG—obesity	2.91e-06	3.06e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS1—obesity	2.88e-06	3.02e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX1—obesity	2.88e-06	3.02e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—POMC—obesity	2.87e-06	3.01e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INS—obesity	2.85e-06	2.99e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—obesity	2.84e-06	2.98e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—obesity	2.82e-06	2.96e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—POMC—obesity	2.81e-06	2.95e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL2—obesity	2.81e-06	2.95e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CD36—obesity	2.8e-06	2.94e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—obesity	2.79e-06	2.93e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INS—obesity	2.79e-06	2.93e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—POMC—obesity	2.77e-06	2.91e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1—obesity	2.76e-06	2.9e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT2—obesity	2.76e-06	2.89e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INS—obesity	2.76e-06	2.89e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL2—obesity	2.75e-06	2.88e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK8—obesity	2.74e-06	2.88e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—obesity	2.73e-06	2.87e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL2—obesity	2.71e-06	2.85e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1—obesity	2.7e-06	2.84e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT2—obesity	2.7e-06	2.83e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1—obesity	2.67e-06	2.8e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT2—obesity	2.66e-06	2.8e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—obesity	2.66e-06	2.79e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—obesity	2.66e-06	2.79e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CD—obesity	2.65e-06	2.78e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CA—obesity	2.62e-06	2.75e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SERPINE1—obesity	2.62e-06	2.75e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARA—obesity	2.61e-06	2.73e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CD—obesity	2.59e-06	2.72e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK8—obesity	2.59e-06	2.71e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—obesity	2.58e-06	2.71e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	2.57e-06	2.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SERPINE1—obesity	2.56e-06	2.69e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CD—obesity	2.56e-06	2.69e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TYK2—obesity	2.55e-06	2.68e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	2.54e-06	2.66e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SERPINE1—obesity	2.53e-06	2.66e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RHOA—obesity	2.53e-06	2.65e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AGT—obesity	2.52e-06	2.65e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—obesity	2.51e-06	2.63e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3R1—obesity	2.5e-06	2.63e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOS3—obesity	2.5e-06	2.63e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TYK2—obesity	2.49e-06	2.62e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RHOA—obesity	2.47e-06	2.6e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOE—obesity	2.47e-06	2.6e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TYK2—obesity	2.46e-06	2.58e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAV1—obesity	2.45e-06	2.57e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3R1—obesity	2.45e-06	2.57e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOS3—obesity	2.45e-06	2.57e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOA1—obesity	2.44e-06	2.57e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RHOA—obesity	2.44e-06	2.56e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOS3—obesity	2.42e-06	2.54e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3R1—obesity	2.42e-06	2.54e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CA—obesity	2.38e-06	2.5e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—obesity	2.36e-06	2.48e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CA—obesity	2.33e-06	2.45e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—obesity	2.33e-06	2.45e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—obesity	2.32e-06	2.44e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MTOR—obesity	2.31e-06	2.42e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CB—obesity	2.31e-06	2.42e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CA—obesity	2.3e-06	2.42e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MTOR—obesity	2.26e-06	2.37e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CB—obesity	2.26e-06	2.37e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CG—obesity	2.23e-06	2.34e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MTOR—obesity	2.23e-06	2.34e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CB—obesity	2.23e-06	2.34e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—obesity	2.2e-06	2.31e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—obesity	2.19e-06	2.3e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARG—obesity	2.15e-06	2.26e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—obesity	2.14e-06	2.25e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CA—obesity	2.14e-06	2.24e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—POMC—obesity	2.12e-06	2.23e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—INS—obesity	2.11e-06	2.22e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—obesity	2.11e-06	2.22e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—obesity	2.1e-06	2.2e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—obesity	2.07e-06	2.17e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—obesity	2.07e-06	2.17e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—obesity	2.04e-06	2.14e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—obesity	2.01e-06	2.11e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CA—obesity	1.98e-06	2.08e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—obesity	1.96e-06	2.06e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CD—obesity	1.96e-06	2.06e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK8—obesity	1.95e-06	2.05e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—obesity	1.95e-06	2.04e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—obesity	1.94e-06	2.04e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—obesity	1.94e-06	2.03e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK8—obesity	1.91e-06	2.01e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—obesity	1.91e-06	2e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK8—obesity	1.89e-06	1.98e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—obesity	1.88e-06	1.97e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CA—obesity	1.86e-06	1.96e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3R1—obesity	1.85e-06	1.94e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NOS3—obesity	1.85e-06	1.94e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—obesity	1.78e-06	1.87e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—obesity	1.75e-06	1.84e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—obesity	1.75e-06	1.83e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—obesity	1.74e-06	1.83e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—obesity	1.72e-06	1.81e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CB—obesity	1.71e-06	1.79e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—obesity	1.69e-06	1.78e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—obesity	1.66e-06	1.74e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—obesity	1.65e-06	1.74e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—obesity	1.65e-06	1.73e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—obesity	1.62e-06	1.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—obesity	1.62e-06	1.7e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—obesity	1.62e-06	1.7e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—obesity	1.6e-06	1.68e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—obesity	1.6e-06	1.68e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—obesity	1.52e-06	1.6e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CA—obesity	1.41e-06	1.48e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CA—obesity	1.38e-06	1.45e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CA—obesity	1.36e-06	1.43e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—obesity	1.25e-06	1.31e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—obesity	1.22e-06	1.28e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—obesity	1.2e-06	1.26e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—obesity	1.15e-06	1.21e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—obesity	1.13e-06	1.18e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—obesity	1.11e-06	1.17e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CA—obesity	1.04e-06	1.09e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—obesity	8.51e-07	8.94e-06	CbGpPWpGaD
